Nyxoah SA
- Last sale
- Nov 12, 2026 · +0.46%
- Market cap
- $38.72M
- 43.03M shares
- Filings
- 179
—
—
—FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−12.2% FY25 yoy
- $38.72M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Cost of Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | €3,694,000 | reported | |
| FY 2024 | 2024-12-31 | €1,552,000 | reported | |
| FY 2023 | 2023-12-31 | €1,656,000 | reported | |
| FY 2022 | 2022-12-31 | €1,150,000 | reported | |
| FY 2021 | 2021-12-31 | €303,000 | reported | |
| FY 2020 | 2020-12-31 | €30,000 | reported |
Surgical & medical instruments & apparatus
Nyxoah SA is the 88th largest of the 144 covered companies the SEC files under this code, by market cap. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
IDXGInterpace Biosciences, Inc.$38.7M17.5%63.5%$41.8MDRIODarioHealth Corp.$22.4M17.3%186.6%$41.2MADGMAdagio Medical Holdings, Inc.$0.0——$40.0MXTNTXtant Medical Holdings, Inc.$133.9M14.2%3.7%$39.3M
NYXHNyxoah SA (this company)———$38.7M
TELATELA Bio, Inc.$80.3M15.8%48.4%$38.0MNXGLNexgel, Inc.$11.4M31.5%26.3%$35.6MNEPHNephros Inc$18.8M32.7%6.4%$35.5MNSPRInspireMD, Inc.$9.0M28.1%543.3%$35.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Nyxoah SA · CIK 1857190 · Engraved from SEC EDGAR